Educational Activities Archives

hotspot_textonly
Filter by Target Audience

Please select the option that best aligns with your profession.

Target Audience
hotspot_textonly
Filter by Topic

Please select the option that best aligns with your topic of interest.

Click on the plus (+) icon to display subtopics.

hotspot_textonly
Filter by Format

Please select the option that best aligns with your preferred format of training.

Formats
hotspot_textonly
Key Term Search

Use the search bar to enter in the title of a training, or other key terms.

Format: Clinical Tool
Modified Objective Opiate Withdrawal Scale
Credit Available:
CE Credit(s): No
Certificate: No
Format: Webinar
Join our 4-session online case-based learning collaborative series focused on treating opioid use disorder. Delve into best practices on Hospital Based Approaches to OUD and explore real-world cases provided by addiction experts, applying knowledge to practical situations. Each session is presented live online and spans 1.5 hours.
Presenter(s):
Andrew King, MD; and Kathryn M. Basques, MSW, MSN, APN, PMHNP-BC
Credit Available:
CE Credit(s): Yes
Designations: AMA PRA Category 1 Credit™, AAPA Category 1 CME, Social Work CE Credit, Nursing Contact Hours, Pharmacy CE Credit, Interprofessional Continuing Education (IPCE) Credit
Format: Clinical Tool
Which patients receiving methadone should be considered good candidates for transfer to buprenorphine? How should I transition a patient from methadone to buprenorphine?
Credit Available:
CE Credit(s): No
Certificate: No
Format: Clinical Tool
Psychiatric pharmacists are advanced practice clinical pharmacists committed to being part of an interdisciplinary team treating substance use disorders, often in combination with serious mental illness. The following SUD toolkits were developed to further the knowledge of pharmacists and other healthcare professionals.
Credit Available:
CE Credit(s): No
Certificate: No
Format: Webinar
The current opioid and drug overdose crisis continues to have a devastating impact on morbidity and mortality in the United States. With the rise in use of potent synthetic opioids like fentanyl in the drug supply, creating linkages to comprehensive substance use related services is critical. Opioid Treatment Programs (OTP) and the comprehensive care and services they provide play a vital role in addressing this need, yet challenges remain. Despite clear evidence of the benefits of OTP’s, access to OTPs in some parts of the country is limited; stigma related to the use of methadone remains a challenge. Yet in the face of these headwinds, many OTPs are providing comprehensive leading-edge services to address the opioid and drug overdose crisis.
Presenter(s):
Mark Parrino, President & CEO of The American Association for the Treatment of Opioid Dependence, Inc. and Jennifer Seib, VP of Strategic Initiatives and Integration at BestSelf Behavioral Health
Credit Available:
CE Credit(s): No
Certificate: Certificate of Attendance, 1-hour